Research ArticleClinical Investigation
Tumor Sink Effect in 68Ga-PSMA-11 PET: Myth or Reality?
Andrei Gafita, Hui Wang, Andrew Robertson, Wesley R. Armstrong, Raphael Zaum, Manuel Weber, Farid Yagubbayli, Clemens Kratochwil, Tristan R. Grogan, Kathleen Nguyen, Fernando Navarro, Rouzbeh Esfandiari, Isabel Rauscher, Bjoern Menze, David Elashoff, Ebrahim S. Delpassand, Ken Herrmann, Johannes Czernin, Michael S. Hofman, Jeremie Calais, Wolfgang P. Fendler and Matthias Eiber
Journal of Nuclear Medicine February 2022, 63 (2) 226-232; DOI: https://doi.org/10.2967/jnumed.121.261906
Andrei Gafita
1Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, UCLA, Los Angeles, California;
2Department of Nuclear Medicine, Klinikum rechts der Isar, Technical University Munich, Munich, Germany;
Hui Wang
2Department of Nuclear Medicine, Klinikum rechts der Isar, Technical University Munich, Munich, Germany;
Andrew Robertson
2Department of Nuclear Medicine, Klinikum rechts der Isar, Technical University Munich, Munich, Germany;
Wesley R. Armstrong
1Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, UCLA, Los Angeles, California;
Raphael Zaum
2Department of Nuclear Medicine, Klinikum rechts der Isar, Technical University Munich, Munich, Germany;
Manuel Weber
3Department of Nuclear Medicine, University of Duisburg–Essen and German Cancer Consortium–University Hospital Essen, Essen, Germany;
Farid Yagubbayli
2Department of Nuclear Medicine, Klinikum rechts der Isar, Technical University Munich, Munich, Germany;
Clemens Kratochwil
4Department of Nuclear Medicine, Heidelberg University Hospital, Heidelberg, Germany;
Tristan R. Grogan
5Department of Medicine Statistics Core, David Geffen School of Medicine, UCLA, Los Angeles, California;
Kathleen Nguyen
1Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, UCLA, Los Angeles, California;
Fernando Navarro
2Department of Nuclear Medicine, Klinikum rechts der Isar, Technical University Munich, Munich, Germany;
6Department of Informatics, Technical University Munich, Munich, Germany;
Rouzbeh Esfandiari
7Excel Diagnostics and Nuclear Oncology Center, Houston, Texas;
Isabel Rauscher
2Department of Nuclear Medicine, Klinikum rechts der Isar, Technical University Munich, Munich, Germany;
Bjoern Menze
6Department of Informatics, Technical University Munich, Munich, Germany;
8Department of Quantitative Biomedicine, University of Zurich, Zurich, Switzerland; and
David Elashoff
5Department of Medicine Statistics Core, David Geffen School of Medicine, UCLA, Los Angeles, California;
Ebrahim S. Delpassand
7Excel Diagnostics and Nuclear Oncology Center, Houston, Texas;
Ken Herrmann
3Department of Nuclear Medicine, University of Duisburg–Essen and German Cancer Consortium–University Hospital Essen, Essen, Germany;
Johannes Czernin
1Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, UCLA, Los Angeles, California;
Michael S. Hofman
9Prostate Cancer Theranostics and Imaging Centre of Excellence, Molecular Imaging and Therapeutic Nuclear Medicine, Peter MacCallum Cancer Centre, and Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia
Jeremie Calais
1Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, UCLA, Los Angeles, California;
Wolfgang P. Fendler
3Department of Nuclear Medicine, University of Duisburg–Essen and German Cancer Consortium–University Hospital Essen, Essen, Germany;
Matthias Eiber
2Department of Nuclear Medicine, Klinikum rechts der Isar, Technical University Munich, Munich, Germany;
Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 63, Issue 2
February 1, 2022
Tumor Sink Effect in 68Ga-PSMA-11 PET: Myth or Reality?
Andrei Gafita, Hui Wang, Andrew Robertson, Wesley R. Armstrong, Raphael Zaum, Manuel Weber, Farid Yagubbayli, Clemens Kratochwil, Tristan R. Grogan, Kathleen Nguyen, Fernando Navarro, Rouzbeh Esfandiari, Isabel Rauscher, Bjoern Menze, David Elashoff, Ebrahim S. Delpassand, Ken Herrmann, Johannes Czernin, Michael S. Hofman, Jeremie Calais, Wolfgang P. Fendler, Matthias Eiber
Journal of Nuclear Medicine Feb 2022, 63 (2) 226-232; DOI: 10.2967/jnumed.121.261906
Tumor Sink Effect in 68Ga-PSMA-11 PET: Myth or Reality?
Andrei Gafita, Hui Wang, Andrew Robertson, Wesley R. Armstrong, Raphael Zaum, Manuel Weber, Farid Yagubbayli, Clemens Kratochwil, Tristan R. Grogan, Kathleen Nguyen, Fernando Navarro, Rouzbeh Esfandiari, Isabel Rauscher, Bjoern Menze, David Elashoff, Ebrahim S. Delpassand, Ken Herrmann, Johannes Czernin, Michael S. Hofman, Jeremie Calais, Wolfgang P. Fendler, Matthias Eiber
Journal of Nuclear Medicine Feb 2022, 63 (2) 226-232; DOI: 10.2967/jnumed.121.261906
Jump to section
Related Articles
Cited By...
- Antihormonal-Treatment Status Affects 68Ga-PSMA-HBED-CC PET Biodistribution in Patients with Prostate Cancer
- The Impact of Peptide Amount on Tumor Uptake to Assess PSMA Receptor Saturation on 68Ga-PSMA-11 PET/CT in Patients with Primary Prostate Cancer
- 177Lu-PSMA Therapy
- Tumor Sink Effect: Myth or Reality?
- Thoughts on "Tumor Sink Effect in 68Ga-PSMA-11 PET: Myth or Reality?"